BIO-key International, Inc.
BKYI
$0.746
$0.0060.81%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 48.68% | -26.32% | -19.88% | 18.03% | -40.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 48.68% | -26.32% | -19.88% | 18.03% | -40.83% |
| Cost of Revenue | 76.97% | -6.71% | -86.34% | -68.50% | -83.67% |
| Gross Profit | 40.24% | -29.44% | 1,356.44% | 393.30% | 172.30% |
| SG&A Expenses | -13.46% | -23.02% | -14.90% | -9.48% | -9.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.52% | -16.44% | -39.99% | -27.96% | -35.10% |
| Operating Income | 34.47% | -25.88% | 53.46% | 70.47% | 30.46% |
| Income Before Tax | 29.97% | -44.33% | 46.88% | 59.79% | 32.78% |
| Income Tax Expenses | -- | -- | 91.69% | -- | -- |
| Earnings from Continuing Operations | 29.97% | -44.33% | 41.65% | 59.79% | 36.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.97% | -44.33% | 41.65% | 59.79% | 36.44% |
| EBIT | 34.47% | -25.88% | 53.46% | 70.47% | 30.46% |
| EBITDA | 36.71% | -33.28% | 54.04% | 74.71% | 31.97% |
| EPS Basic | 80.00% | 50.43% | 89.77% | 87.86% | 78.72% |
| Normalized Basic EPS | 80.00% | 50.41% | 91.19% | 88.87% | 77.08% |
| EPS Diluted | 80.00% | 50.43% | 89.77% | 87.86% | 78.72% |
| Normalized Diluted EPS | 80.00% | 50.41% | 91.19% | 88.87% | 77.08% |
| Average Basic Shares Outstanding | 250.04% | 191.12% | 470.50% | 231.06% | 198.67% |
| Average Diluted Shares Outstanding | 250.04% | 191.12% | 470.50% | 231.06% | 198.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |